| Application no. and date | 15185714.1 (espacenet) (Federated) (European Patent Register), 20050303 | | Patent/reg. no. and date | DK/EP 2985039, 20180801 | | Publication date | 20160217 | | Priority no. and date | US 550015 P, 20040303 | | EP pub. no. and date |
EP 2985039 20160217 | | Effective date | | | Applicant/owner | ReVance Therapeutics, Inc., 7555 Gateway Blvd.
Newark, CA 94560, US | | Applicant ref. no. | P81313269DK01E | | Inventor | Dake, Michael D., 665 Gerona Road
Stanford, CA 94305, US,
Waugh, Jacob M., 555 Bryant St., 817
palo Alto, CA 94301, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/40 (2006.01) , A61K 39/42 (2006.01) , A61K 47/18 (2017.01) , A61K 47/42 (2017.01) , A61K 51/00 (2006.01) | | Title | Topisk påføring og transdermal indgivelse af botulinumtoksiner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
